Vertex Pharmaceuticals

VRTX 4.75 02/15/13
CUSIP 92532FAM2 BOND
Reported in filings as: VERTEX PHARMACEUTICALS INC
Option CUSIPs: 92532F900 92532F950
Vertex Pharmaceuticals profile

Across other SEC filings

Insiders · Form 4

Net insider transactions, 12 months -$158M 0 filings with purchases ($0), 52 filings with sales ($158M)
Latest filings
All Vertex Pharmaceuticals insider filings

Annual & quarterly reports

  • 10-K · FY2025 Filed 2026-02-13
    Business · Risk Factors · Management's Discussion and Analysis
  • 10-Q · Q3 FY2026 Filed 2026-11-03
    Management's Discussion and Analysis · Controls and Procedures · Legal Proceedings · Risk Factors
All Vertex Pharmaceuticals SEC filings

Federal lobbying

Spend, trailing 12 months $5.1M Through Q3 2026, from quarterly LD-2 reports
Vertex Pharmaceuticals lobbying profile

Ownership explorer

Security Details

CUSIP 92532FAM2
Symbol VRTX 4.75 02/15/13
Type Bond
Company Vertex Pharmaceuticals

Other securities from this issuer

Name Symbol CUSIP Type
VERTEX PHARMACEUTICALS INC VRTX 92532F100 Common stock
VERTEX PHARMACEUTICALS INC VRTX 3.35 10/01/15 92532FAN0 Bond
VERTEX PHARMACEUTICALS INC VRTX 5.75 02/15/11 * 92532FAF7 Bond
VERTEX PHARMACEUTICALS INC VRTX 5 03/14/07 92532FAB6 Bond
VERTEX PHARMACEUTICALS INC VRTX 5 09/19/07 144A 92532FAC4 Bond
VERTEX PHARMACEUTICALS INC VRTX 92532FAA8 Bond
VERTEX PHARMACEUTICALS INC VRTX 5.75 02/15/11 92532FAK6 Bond
VERTEX PHARMACEUTICALS INC VRTX 5 09/19/07 REGS 92532FAD2 Bond

Identifier History

Type Value From To
CUSIP 92532FAM2 2008-09-30 Current